RCKT•benzinga•
Rocket Pharmaceuticals Announces New England Journal Of Medicine Publication Of Phase 1 RP-A501 Long-Term Data And Presents At Late-Breaking Scientific Sessions At 2024 American Heart Association Conference; RP-A501 Demonstrated Safety And Meaningful Effi
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 18, 2024 by benzinga